303 related articles for article (PubMed ID: 28762163)
1. Polycystin 2-dependent cardio-protective mechanisms revealed by cardiac stress.
Giehl E; Lemos FO; Huang Y; Giordano FJ; Kuo IY; Ehrlich BE
Pflugers Arch; 2017 Nov; 469(11):1507-1517. PubMed ID: 28762163
[TBL] [Abstract][Full Text] [Related]
2. Decreased polycystin 2 expression alters calcium-contraction coupling and changes β-adrenergic signaling pathways.
Kuo IY; Kwaczala AT; Nguyen L; Russell KS; Campbell SG; Ehrlich BE
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16604-9. PubMed ID: 25368166
[TBL] [Abstract][Full Text] [Related]
3. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.
Gainullin VG; Hopp K; Ward CJ; Hommerding CJ; Harris PC
J Clin Invest; 2015 Feb; 125(2):607-20. PubMed ID: 25574838
[TBL] [Abstract][Full Text] [Related]
4. Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy.
Paavola J; Schliffke S; Rossetti S; Kuo IY; Yuan S; Sun Z; Harris PC; Torres VE; Ehrlich BE
J Mol Cell Cardiol; 2013 May; 58():199-208. PubMed ID: 23376035
[TBL] [Abstract][Full Text] [Related]
5. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review.
Pietrzak-Nowacka M; Safranow K; Płońska-Gościniak E; Nowacki A; Późniak P; Gutowski P; Ciechanowski K
Kidney Blood Press Res; 2024; 49(1):9-19. PubMed ID: 38096797
[TBL] [Abstract][Full Text] [Related]
7. Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.
Jung HJ; Dixon EE; Coleman R; Watnick T; Reiter JF; Outeda P; Cebotaru V; Woodward OM; Welling PA
Physiol Genomics; 2023 Nov; 55(11):565-577. PubMed ID: 37720991
[TBL] [Abstract][Full Text] [Related]
8. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.
Freedman BS; Lam AQ; Sundsbak JL; Iatrino R; Su X; Koon SJ; Wu M; Daheron L; Harris PC; Zhou J; Bonventre JV
J Am Soc Nephrol; 2013 Oct; 24(10):1571-86. PubMed ID: 24009235
[TBL] [Abstract][Full Text] [Related]
9. Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD.
Brill AL; Ehrlich BE
Cell Signal; 2020 Feb; 66():109490. PubMed ID: 31805375
[TBL] [Abstract][Full Text] [Related]
10. Genetic Mechanisms of ADPKD.
Kim DY; Park JH
Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
[TBL] [Abstract][Full Text] [Related]
11. Polycystin-1 negatively regulates Polycystin-2 expression via the aggresome/autophagosome pathway.
Cebotaru V; Cebotaru L; Kim H; Chiaravalli M; Boletta A; Qian F; Guggino WB
J Biol Chem; 2014 Mar; 289(10):6404-6414. PubMed ID: 24459142
[TBL] [Abstract][Full Text] [Related]
12. XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice.
Krappitz M; Bhardwaj R; Dong K; Staudner T; Yilmaz DE; Pioppini C; Westergerling P; Ruemmele D; Hollmann T; Nguyen TA; Cai Y; Gallagher AR; Somlo S; Fedeles S
J Am Soc Nephrol; 2023 Jan; 34(1):110-121. PubMed ID: 36270750
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Localized Polycystin-2 plays a Functional Role in Natriuretic Peptide Production and its Absence Contributes to Hypertension.
Elliott B; Márquez-Nogueras KM; Thuo P; DiNello E; Knutila RM; Fritzmann GE; Willis M; Chapman AB; Cao Q; Barefield DY; Kuo IY
bioRxiv; 2024 Jan; ():. PubMed ID: 38260706
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells.
Aguiari G; Banzi M; Gessi S; Cai Y; Zeggio E; Manzati E; Piva R; Lambertini E; Ferrari L; Peters DJ; Lanza F; Harris PC; Borea PA; Somlo S; Del Senno L
FASEB J; 2004 May; 18(7):884-6. PubMed ID: 15001556
[TBL] [Abstract][Full Text] [Related]
15. Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin.
Kim I; Ding T; Fu Y; Li C; Cui L; Li A; Lian P; Liang D; Wang DW; Guo C; Ma J; Zhao P; Coffey RJ; Zhan Q; Wu G
J Am Soc Nephrol; 2009 Dec; 20(12):2556-69. PubMed ID: 19939939
[TBL] [Abstract][Full Text] [Related]
16. Ciliary exclusion of Polycystin-2 promotes kidney cystogenesis in an autosomal dominant polycystic kidney disease model.
Walker RV; Keynton JL; Grimes DT; Sreekumar V; Williams DJ; Esapa C; Wu D; Knight MM; Norris DP
Nat Commun; 2019 Sep; 10(1):4072. PubMed ID: 31492868
[TBL] [Abstract][Full Text] [Related]
17. Polycystin-1 dependent regulation of polycystin-2 via GRP94, a member of HSP90 family that resides in the endoplasmic reticulum.
Yao Q; Outeda P; Xu H; Walker R; Basquin D; Qian F; Cebotaru L; Watnick T; Cebotaru V
FASEB J; 2021 Oct; 35(10):e21865. PubMed ID: 34486178
[TBL] [Abstract][Full Text] [Related]
18. A mutation affecting polycystin-1 mediated heterotrimeric G-protein signaling causes PKD.
Parnell SC; Magenheimer BS; Maser RL; Pavlov TS; Havens MA; Hastings ML; Jackson SF; Ward CJ; Peterson KR; Staruschenko A; Calvet JP
Hum Mol Genet; 2018 Oct; 27(19):3313-3324. PubMed ID: 29931260
[TBL] [Abstract][Full Text] [Related]
19. A tale of two tails: ciliary mechanotransduction in ADPKD.
Cantiello HF
Trends Mol Med; 2003 Jun; 9(6):234-6. PubMed ID: 12829010
[TBL] [Abstract][Full Text] [Related]
20. A polycystin-2 (TRPP2) dimerization domain essential for the function of heteromeric polycystin complexes.
Giamarchi A; Feng S; Rodat-Despoix L; Xu Y; Bubenshchikova E; Newby LJ; Hao J; Gaudioso C; Crest M; Lupas AN; Honoré E; Williamson MP; Obara T; Ong AC; Delmas P
EMBO J; 2010 Apr; 29(7):1176-91. PubMed ID: 20168298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
